NEOGENOMICS INC — Director's Dealing 2019

Nov 18, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2019-11-15

Reporting Person: BALLIET JENNIFER (VP and Chief Culture Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-11-15	Common Stock	M	6667	$7.52	Acquired	29529	Direct
2019-11-15	Common Stock	M	166	$8.03	Acquired	29695	Direct
2019-11-15	Common Stock	S	6833	$23.45	Disposed	22862	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-11-15	Stock Option (Right to Buy)	$7.52	M	6667	Disposed	2022-04-28	Common Stock (6667.0)	Direct
2019-11-15	Stock Option (Right to Buy)	$8.03	M	166	Disposed	2023-02-26	Common Stock (166.0)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$19.6	2024-03-01	Common Stock (17496.0)	17496	Direct

Footnotes

F1: On April 28, 2017, Jennifer Balliet was granted 60,000 stock options which vest ratably over the first three anniversary dates of the grant date.

F2: On February 26, 2018, Jennifer Balliet was granted 72,500 stock options which vest ratably over the first three anniversary dates of the grant date.

F3: On March 1, 2019, Jennifer Balliet was granted 17,496 stock options which vest ratably over the first four anniversary dates of the grant date.